1. Home
  2. CLST vs IBIO Comparison

CLST vs IBIO Comparison

Compare CLST & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Catalyst Bancorp Inc.

CLST

Catalyst Bancorp Inc.

HOLD

Current Price

$15.97

Market Cap

66.9M

Sector

N/A

ML Signal

HOLD

Logo iBio Inc.

IBIO

iBio Inc.

HOLD

Current Price

$2.19

Market Cap

72.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLST
IBIO
Founded
1922
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.9M
72.2M
IPO Year
2021
2009

Fundamental Metrics

Financial Performance
Metric
CLST
IBIO
Price
$15.97
$2.19
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$4.75
AVG Volume (30 Days)
9.5K
913.6K
Earning Date
04-27-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
171.79
73.08
EPS
0.56
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$28.48
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.93
$0.56
52 Week High
$18.16
$3.82

Technical Indicators

Market Signals
Indicator
CLST
IBIO
Relative Strength Index (RSI) 35.95 50.81
Support Level $15.20 $2.02
Resistance Level $15.97 $2.82
Average True Range (ATR) 0.29 0.16
MACD -0.11 0.04
Stochastic Oscillator 0.00 88.37

Price Performance

Historical Comparison
CLST
IBIO

About CLST Catalyst Bancorp Inc.

Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It derives income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.

About IBIO iBio Inc.

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.

Share on Social Networks: